CT provides noninvasive evaluation of cardiac structure and function. It uses ionizing radiation and reconstruction algorithms to form images. Advancements include increasing detector rows for wider coverage and shorter scan times. CT can assess coronary calcium scoring, coronary angiography, bypass graft/stent patency, cardiac morphology/function, and pericardial diseases. It is useful for diagnosing chest pain, coronary anomalies, and evaluating surgical candidates. Risks include radiation exposure and contrast nephropathy, so appropriate patient selection is important.

1. Computed tomography (CT) - a technique that can noninvasively fully evaluate
 cardiac structure
 function.
The basic principle of CT technology is the use of ionizing radiation within a gantry
rotating around the patient in which x-rays are detected on a detector array and
converted through reconstruction algorithms to images.

2. Types of CT
1. EBCT (Electron beam CT)
2. MDCT ( Multidetector CT)
The most notable technical advance is progressive increase in the number of detector
rows (or slices). Each row is a narrow channel, approximately 0.625 mm in width,
through which x-rays are detected on scintillation crystals. The number of detector
rows aligned in an array has increased from a single detector to 4, 16, and 64
(present standard technology) and now on to “wide” detectors of 256 to 320 rows.

3. The increase in the number of rows leads to wider coverage (more of the heart
viewed simultaneously, e.g., 64 rows of 0.625-mm width produces
approximately 4 cm of coverage, leading to shorter scan acquisition times and
consequently reduced radiation exposure and contrast requirements.

4. EBCT :
EBCT uses an electron beam (current 630 mA, voltage 130 kV) that is deflected
via a magnetic coil and focused to strike a series of four tungsten targets
located beneath the patient. The electron beam is magnetically swept along
the tungsten targets at a 210-degree arc. EBCT has no moving parts.

5. MDCT :
Multidetector CT (MDCT) scanners produce images by rotating an x-ray tube
around a circular gantry through which the patient advances on a moving table.

6. Scan Modes
There are two basic scan modes in cardiac CT, helical (spiral) and axial (sequential, step
& shoot) scanning.
Helical (spiral) scanning : Most current MDCT scanners use spiral, retrospectively gated
acquisition techniques. Helical scanning involves continuous radiation exposure and
table movement (the patient is moved through the rotating x-ray beam), during which
the detector arrays receive projection data from multiple contiguous slices of the
patient.
Axial (sequential, step & shoot) scanning : axial imaging involves sequential scanner
“snapshots,” in between which the x-ray tube is turned off and the table is moved to a
different position for the next image to be acquired.

8. ECG gating
a. Prospective triggering: The trigger signal is derived from the patient’s ECG based
on a prospective estimation of the RR interval. The scan is usually triggered to
begin at a defined point after the R wave, usually allowing image acquisition to
occur during diastole.
Advantage: ● dose efficient (80% reduction in x-ray exposure)
Disadvantage : ● limited portion of cardiac cycle data set obtained
● greatly depends on the regularity of patient’s heart rate

9. b. Retrospective gating : Collects data during the entire cardiac cycle. Once scan is
complete , data from specific periods of the cardiac cycle are used for image
reconstruction by retrospective referencing to the ECG signal.
Advantage : allows assessment of cardiac function via four-dimensional
reconstruction.
Disadvantage : higher radiation dose exposure.

10. Contrast enhanced imaging :
Administration of iodinated contrast media increases the attenuation of the blood
pool, improving vessel delineation and tissue characterization. When using contrast,
image acquisition must be timed such that images are acquired when the blood pool
enhancement in the target structure is maximal.
Various techniques exist to time the arrival of the contrast bolus in the arterial
tree and initiate imaging.

11. Indications:
A. Evaluation of chest pain in patients at low to intermediate pretest probability of
disease and persistent chest pain after an equivocal stress test.
B. Suspicion of coronary artery anomalies. MDCT has very high sensitivity and
specificity for coronary anomalies.
C. Pulmonary vein evaluation can be performed, often before or after pulmonary vein
isolation for atrial fibrillation.
D. Evaluation of cardiac masses when other modalities such as TTE, TEE, or MRI are
unrevealing.
E. Evaluation of pericardial disease when other modalities such as TTE, TEE, or MRI
are unrevealing.
F. Assessment of anatomy in complex congenital heart disease.

12. G. Presurgical evaluation, particularly before redo open heart surgery. MDCT can aid in
describing prior bypass graft location, identifying safe sites for surgical approach.
H. Assessing graft patency after prior bypass surgery is feasible in many cases, though
sometimes limited by artifacts related to calcium and surgical clips.
I. Evaluation of aortic disease. MDCT is the test of choice for evaluating aortic
aneurysm and suspected aortic dissection.
J. Evaluation of suspected pulmonary embolism

13. CONTRAINDICATIONS:
Unlike with cardiac MRI, few absolute contra indications exist for cardiac CT. However,
there are important risks associated with radiation and/or contrast exposure that must be
weighed against the benefits of the scan.
Absolute contraindications :
A. Renal insufficiency. Given the potential for contrast nephropathy, patients with
significant renal insufficiency (i.e., Cr > 1.6 mg/dL) should not undergo contrast-enhanced
CT unless the information from the scan is critical and the risks/benefits
are thoroughly discussed with the patient.
B. Known history of anaphylactic contrast reactions A prior anaphylactic response to
contrast is generally felt to be an absolute contraindication to intravenous iodinated
contrast administration at many institutions.
C. Pregnancy
D. Clinical instability

14. Relative contraindications
A. Contrast (iodine) allergy. Patients with allergic reactions to contrast should be
pretreated with diphenhydramine and steroids before contrast administration.
B. Recent intravenous iodinated contrast administration. Patients who have
received an intravenous dose of iodinated contrast should avoid contrast-enhanced
CT scanning for 24 hours to reduce the risk of contrast nephropathy.
C. Hyperthyroidism. Iodinated contrast is contraindicated in the setting of
uncontrolled hyperthyroidism due to possible precipitation of thyrotoxicosis.
D. Atrial fibrillation or any irregular heart rhythm, is a contraindication to coronary
CT angiography due to image degradation from suboptimal ECG gating.
E. Inability to breath hold for at least 10 seconds. Image quality will be significantly
reduced due to respiratory motion artifact if the patient cannot comply with breath
hold instructions.
F. Morbid obesity
G. Severe coronary calcium

15. SAFETY
A. Radiation exposure : Radiation doses of cardiac CT scans vary greatly depending
on the scan parameter settings, scan range (cranial-caudal length of the scan),
gender (women receive more radiation due to breast tissue), and patient body
habitus (obesity increases exposure).
● chest x-ray is 0.04 to 0.10 mSv,
● average annual background radiation 3 to 3.6 mSv.
● Invasive diagnostic coronary angiography 2.1 to 4 mSv.
● coronary CT angiography 4 to 11 mSv. With use of prospective-ECG triggering,
axial imaging modes, and software adaptations, recent studies have reported the
feasibility of CT coronary angiography with comparable image quality and
substantially reduced radiation doses (i.e., 1.1 to 3.0 mSv). This remains an area of
active investigation.

16. B. Contrast nephropathy : Iodinated contrast media can cause renal ischemia by
reducing renal blood flow or increasing oxygen demand and may also have a direct
toxic effect on tubular epithelial cells. If a contrast-enhanced CT study is necessary in
patients with significant renal insufficiency, prophylactic measures should be taken
● saline hydration
● n-acetylcysteine
● use of low osmolar agents
● sodium bicarbonate infusion

18. CLINICAL APPLICATIONS
A. Coronary calcium scoring
Coronary calcium is a surrogate marker for coronary atherosclerotic plaque. Coronary
artery calcium score is directly proportional to the overall extent of atherosclerosis,
although typically only a minority (approximately 20%) of plaque is calcified.
Complete absence of coronary artery calcium makes the presence of significant
coronary luminal obstruction highly unlikely and indicates a very low risk of future
coronary events.
Men, CKD, diabetics tend to have higher coronary calcium scores.
Contrast is not necessary because calcium is readily identified secondary to its very
high x-ray attenuation coefficient (high Hounsfield unit score).

20. The Agatston coronary artery calcium (CAC) score is the most frequently
used scoring system. It is derived by measuring the area of each calcified coronary
lesion and multiplying it by a coefficient of 1 to 4, depending on the maximum
CT attenuation within that lesion.
Volume score
Mass score
A coronary calcium coverage score : multivessel coronary calcium, the number of
calcified lesions and diffuse spotty pattern (small foci <3 mm) are associated with a
higher clinical risk.
The CAC score can be classified into five groups:
1) zero, no coronary calcification;
2) 100, mild coronary calcification;
3) > 100 to 399, moderate calcification;
4) >400 to 999, severe calcification;
5) > 1000, extensive calcification.

21. In comparison with a CAC score of zero, the presence of any CAC is associated with a
fourfold risk of coronary events over 3 to 5 years.
In patients at intermediate clinical risk for coronary events (e.g., by Framingham
score), the CAC score can help to reclassify patients to a higher or lower risk group. For
instance, a CAC score of zero confirms low risk of events. Conversely, a CAC score of
greater than 400 is observed with a significant cardiac event rate (greater than 2 %/year)
in patients who appear to be intermediate risk by Framingham score.
Because statins have no documented effect on CAC progression, there is no value in
repeating CAC in persons with a score of greater than 100 or the 75th percentile.
However, not every atherosclerotic plaque is calcified, and even the detection of
a large amount of calcium does not imply the presence of significant stenoses.
Therefore, it adds only incrementally to traditional risk assessment and should
not be used in isolation. The test is most useful in intermediate risk populations,
in which a high or low score may reclassify individuals to a higher or lower risk
group. Unselected screening is not recommended.

22. CAC and Stenosis Severity : Significant coronary artery stenosis (>50%) by angiography is
frequently associated with the presence of coronary artery calcium. However, the
severity of angiographic coronary artery stenosis is not directly related to the total CAC.
CAC and Myocardial Ischemia : Good correlation between CT and myocardial perfusion
SPECT for identifying both subclinical CAD and silent myocardial ischemia in a generally
asymptomatic population who had risk factors for CAD development. Few patients with
CACS <400 had a perfusion defect, whereas nearly half of the patients with CACS >400
had an abnormal SPECT.

23. Coronary CT angiography : The primary clinical application of cardiac CT is the
performance of noninvasive coronary CT angiography among patients with symptoms
suggestive of myocardial ischemia. The overall accuracy of 64-row CT angiography
included a sensitivity of 87% to 99% and specificity of 93% to 96%.
Coronary CT angiography for evaluating CAD is most useful in low- to intermediate-risk
patients with angina or anginal equivalent. The negative predictive value of coronary CT
angiography is uniformly high in studies, approaching 93% to 100%; in other words,
coronary CT angiography is an excellent modality for ruling out coronary disease.

25. Patients who are generally poor candidates for coronary CT angiography include
1. those likely to have heavily calcified coronary arteries (older than 75, endstage
renal disease, Paget's disease), atrial fibrillation /flutter, frequent ventricular
ectopic beats, or uncontrolled tachycardia.
2. Known severe CAD is generally a contraindication to coronary CT angiography.
However, cardiac CT has been shown to have high sensitivity and specificity
for assessment of bypass graft patency in patients with previous coronary artery
bypass grafting (CABG)
3. Patients with prior coronary artery stents are generally poor candidates for CAD,
although selected patients with proximal LAD or left main stents may be
successfully imaged. Current CT technology does not allow for the accurate
quantification of in-stent stenosis severity.

26. Noncalcified plaque appears as a low to intermediate attenuation irregularity in the
vessel wall. Calcified plaques are bright, high-attenuation lesions in the vessel wall and
may be associated with positive remodeling of the vessel. Densely calcified plaques are
often associated with calcium blooming artifact, which can lead to overestimation of
luminal stenosis severity.
The accuracy of coronary CT angiography is highest in the larger proximal to
medium vessels, which are more likely to benefit from an invasive management
strategy. Coronary stenoses are generally categorized as mild (less than 50%
diameter stenosis), moderate (50% t070% stenosis), or severe (greater than 70%
stenosis). Similar to results with invasive coronary angiography, the determination of an
anatomic stenosis is only modestly predictive of inducible ischemia. A 50% or greater
stenosis on cardiac CT has a 30% to 50% likelihood of demonstrable ischemia on
myocardial perfusion imaging .

27. Detection of Noncalcified Plaque
Defined as any coronary arterial wall lesion with an x-ray attenuation detectably below
the iodine contrast medium but higher than surrounding tissue.
Such plaque is difficult to quantify, with limited accuracy and reproducibility. Detection
requires maximal spatial and temporal resolution and minimized image noise with
higher radiation exposures. Compared with intravascular ultrasound, the sensitivity of
coronary MDCT is approximately 80%.
Detection of vulnerable plaques
Plaque features proposed to be associated with greater risk for plaque rupture or acute
coronary syndromes include ●low-attenuation plaque (plaque <30 HU), ●outward
arterial remodeling (artery diameter ratio of the involved segment to a proximal
reference of 1.1 or greater), and ●a spotty pattern (<3 mm in size) of calcification.
In particular, both low-attenuation plaque and outward arterial remodeling have been
associated with increased risk of acute coronary events.
A threefold worse cardiovascular prognosis has been found in the setting of a greater
number of coronary vessels and of coronary artery segments involved with plaque.

28. Bypass graft imaging :
1. Graft location : MDCT can accurately characterize the origin, course, and touchdown
of prior bypass grafts
2. Graft patency : Using a protocol similar to that used for coronary artery assessment
(less than 1 mm slice thickness), patency of both arterial and venous bypass
grafts can be assessed. Recent studies have suggested that the sensitivity and
specificity of MDCT for detecting stenosis or occlusion of bypass grafts, when
compared with invasive angiography, is 97% and 97%, respectively. Occasionally,
artifacts related to metallic clips can interfere with assessment of the distal
anastomosis of an arterial graft (internal mammary or radial artery graft).

30. Stent patency:
Image artifact from metallic stents limits the application in patients with prior
coronary stent procedures. Small stents are difficult to evaluate and prone to
noninterpretability. However, 90% accuracy can be obtained in stents 3 mm or greater
in diameter with the use of sharp kernel and wide display window. Quantitative
assessment of within-stent contrast density may assist in the diagnosis.

31. Coronary artery anomalies :
MDCT is an excellent modality for assessing patients with known or suspected coronary
artery anomalies. MDCT can accurately assess the origin and course of anomalous
coronaries, and can describe the relationship of the coronary artery to neighboring
structures. Although MRI can also be used to assess anomalous coronaries without
the need for radiation exposure, the spatial resolution, ease of data acquisition, and
reliable image quality of MDCT make it a reasonable first choice. Intramyocardial
bridging can also be detected with high sensitivity.

32. Cardiac morphology/function :
Contrast-enhanced MDCT can provide high resolution morphologic images of the
cardiac chambers as well as accurate assessment of right and left ventricular systolic
function. However, other imaging modalities such as echocardiography or MRI, which
do not require radiation exposure, are generally preferred initially for assessing cardiac
morphology.
1. Patients with prior myocardial infarction can have fibrous replacement of
myocardium with or without calcification, ventricular wall thinning, aneurysm
formation and cavitary thrombus.
2. Ventricular dysplasia is characterized by: fibrous and/or fatty replacement of
myocardium, ventricular wall thinning and/or focal aneurysm formation, and
ventricular cavity dilation with regional or global wall motion abnormalities.
3. Mass : CT provides somewhat less information about tissue type than cardiac
MRI.

34. Pericardial diseases :
The pericardium appears as a thin line (1 to 2 mm) surrounding the heart, usually
visible with a small amount of adjacent pericardiaI fat. The pericardium normally
enhances with contrast administration; hyperenhancement of the pericardium in the
appropriate clinical setting is characteristic of pericarditis.
1. By CT, congenital absence of the pericardium is easily diagnosed.
2. Findings of pericardial constriction on CT include irregular pericardiaI thickening
and calcification, conical or tubular compression of one or both ventricles,
enlargement of one or both atria, dilation of the IVC, and a characteristic diastolic
bounce of the interventricular septum.
3. Pericardial effusions can be reliably detected by CT. Pericardial tamponade is
better evaluated by echocardiography, however, due to its ability to provide
hemodynamic information.
4. A pericardiaI cyst will appear as a well circumscribed paracardiac mass with
characteristic water attenuation (H.U. = 0), usually in the right costophrenic
angle.
5. Both primary neoplasms and, more commonly, metastatic neoplasms can be
visualized in the pericardium.

36. Congenital heart disease :
MDCT may be used in selected patients in whom echocardiography is non-diagnostic
or inadequate and MRI is not available.
The ability to evaluate cardiovascular anatomy in multiple planes is often helpful for
delineating cardiac morphology in congenital heart disease, particularly with regard
to the relationship of the great vessels, pulmonary veins, and coronary arteries.
Specific situations in which MDCT is helpful include
1. "hard-to-find" adult shunt detection (sinus venosus atrial septal defect, patent
ductus arteriosus);
2. visualization of pulmonary arteries in cyanotic congenital heart disease;
3. precise definition of aortic anatomy in Marfan's syndrome or coarctation;
4. definition of partial or total anomalous pulmonary venous drainage.

37. Diseases of the aorta constitute a common and important indication for CT
examinations.
Contrast-enhanced MDCT is nearly 100% sensitive and specific for
evaluating acute aortic syndromes.
1. Acute aortic dissection is characterized on CT by visualization of a dissection flap
(i.e., separation of the intima from the media) that forms true and false lumens. The
CT study can characterize the origin and extent of the dissection, classify it as Type A
or B, assess for concomitant aneurysmal aortic dilatation, and identify branch vessels
involvement.
2. Aortic intramural hematomas are believed to be caused by spontaneous
hemorrhage of the vaso vasorum into the medial layer. They appear as crescent-
shaped areas of increased attenuation with eccentric aortic wall thickening. Unlike
dissections, hematomas do not spiral around the aorta.
3. Aortic aneurysm is a permanent dilation of 150% of the normal aortic caliber
(usually greater than 5 cm in the thoracic aorta and greater than 3 cm in the
abdominal aorta).
4. Penetrating atherosclerotic ulcer. These tend to be focal lesions of the descending
thoracic aorta that appear as contrast-filled irregular outpouchings of the aortic wall.

40. Evaluation of pulmonary veins :
In the context of electrophysiology interventions such as pulmonary vein isolation (PVI),
preprocedural MDCT can be used to define pulmonary venous anatomy and identify
supernumerary veins, and postprocedural MDCT can be used to evaluate for pulmonary
vein stenosis. Additionally, in the setting of congenital heart disease, CT can be used to
identify anomalous pulmonary venous return.

41. Evaluation of pulmonary embolism :
MDCT is highly accurate in detecting PE, which appear as a filling defect in the
pulmonary arteries. This modality is most sensitive for proximal (main segmental
branches) thrombi, and small, distal emboli may be missed.

42. Valvular heart disease :
Visualization of the valve leaflets, particularly the aortic valve, is feasible with newer-
generation scanners due to their improved temporal resolution. Nonenhanced
MDCT is also useful for assessing prosthetic mechanical valve leaflet motion.

43. Surgical planning :
The utility of MDCT in surgical planning before cardiothoracic surgery, particularly for
reoperations, is increasingly recognized. Preoperative scans can evaluate the
proximity of mediastinal structures to the sternum (i.e., aorta, right ventricle, bypass
grafts); the degree of aortic calcification (i.e., to guide cannulation sites); and
concomitantly provide information about cardiac morphology (e.g., presence of a
ventricular aneurysm). Ongoing studies are evaluating whether this added
information might reduce intraoperative and perioperative complications.

44. Peripheral arteries :
MDCT can also be used to evaluate peripheral arteries, including the carotid, renal,
visceral, and lower-extremity vessels. Indeed, imaging these vessels is generally more
straightforward than coronary imaging, due to their large caliber and minimal motion.
CT can be used for planning and follow-up of vascular disease in these peripheral
vascular beds.

45. Emerging Applications
Detection of myocardial scar and viability
Features suggestive of prior myocardial infarction and nonviable myocardium
On first-pass imaging : ●Myocardial hypoattenuation (<50% of the surrounding
myocardium) and, ●Myocardial thickness <5 mm.
Late myocardial enhancement imaging with infusion of additional contrast medium and a
delay of approximately 10 minutes. The kinetics of iodinated contrast material is similar to
that of gadolinium, with accumulation within the interstitial space of myocardial fibrosis.
Under delayed imaging, contrast preferentially accumulates within areas of scarring and
can be detected on delayed imaging. Delayed enhancement on cardiac CT indicates
regions of myocardium with reduced likelihood of functional recovery and patients whose
ejection fraction will remain lower after myocardial infarction, particularly when a
transmural pattern of delayed enhancement is present.

47. 2010 ACCF/AHA Guidelines for assessment of cardiovascular risk in asymptomatic
adults
Recommendations for Calcium Scoring Methods
Class IIa
Measurement of CAC is reasonable for cardiovascular risk assessment in asymptomatic
adults at intermediate risk (10% to 20% 10-year risk) (Level of Evidence: B)
Class IIb
Measurement of CAC may be reasonable for cardiovascular risk assessment in persons
at low to intermediate risk (6% to 10% 10-year risk) (Level of Evidence: B)
Class III: No Benefit
Persons at low risk (<6% 10-year risk) should not undergo CAC measurement for
cardiovascular risk assessment (Level of Evidence: B)
Recommendations for Coronary CT Angiography
Class III: No Benefit
Coronary computed tomography angiography is not recommended for cardiovascular
risk assessment in asymptomatic adults (Level of Evidence: C)